e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Waldencast plc - Class A Ordinary Share
(NQ:
WALD
)
1.690
-0.010 (-0.59%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
72,539
Open
1.700
Bid (Size)
1.650 (200)
Ask (Size)
1.870 (400)
Prev. Close
1.700
Today's Range
1.690 - 1.840
52wk Range
1.450 - 3.540
Shares Outstanding
9,342,874
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 27, 2026
Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its extensive national network of practices
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 25, 2026
It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing...
From
Waldencast plc
Via
GlobeNewswire
Performance
YTD
-1.2%
-1.2%
1 Month
+7.3%
+7.3%
3 Month
-32.9%
-32.9%
6 Month
+8.3%
+8.3%
1 Year
-44.8%
-44.8%
More News
Read More
Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 17, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 06, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 05, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
February 03, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 30, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 28, 2026
From
Waldencast plc
Via
GlobeNewswire
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
January 27, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
January 27, 2026
From
Waldencast plc
Via
GlobeNewswire
CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 26, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 26, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
January 21, 2026
From
Waldencast plc
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
November 24, 2025
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 16, 2025
From
Waldencast plc
Via
GlobeNewswire
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 14, 2025
From
Waldencast plc
Via
GlobeNewswire
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
November 12, 2025
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 08, 2025
From
Waldencast plc
Via
GlobeNewswire
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025
From
Waldencast plc
Via
GlobeNewswire
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
August 19, 2025
Via
Benzinga
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 18, 2025
From
Waldencast plc
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Monday?
↗
August 18, 2025
Via
Chartmill
Earnings Scheduled For August 18, 2025
↗
August 18, 2025
Via
Benzinga
Frequently Asked Questions
Is Waldencast plc - Class A Ordinary Share publicly traded?
Yes, Waldencast plc - Class A Ordinary Share is publicly traded.
What exchange does Waldencast plc - Class A Ordinary Share trade on?
Waldencast plc - Class A Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Waldencast plc - Class A Ordinary Share?
The ticker symbol for Waldencast plc - Class A Ordinary Share is WALD on the Nasdaq Stock Market
What is the current price of Waldencast plc - Class A Ordinary Share?
The current price of Waldencast plc - Class A Ordinary Share is 1.690
When was Waldencast plc - Class A Ordinary Share last traded?
The last trade of Waldencast plc - Class A Ordinary Share was at 02/27/26 04:00 PM ET
What is the market capitalization of Waldencast plc - Class A Ordinary Share?
The market capitalization of Waldencast plc - Class A Ordinary Share is 15.79M
How many shares of Waldencast plc - Class A Ordinary Share are outstanding?
Waldencast plc - Class A Ordinary Share has 16M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.